CUAMC
ADAP
China Universal Asset Management Company’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,285
| Closed | -$4.12K | – | 429 |
|
|
2023
Q3 | $4.12K | Buy |
5,285
+3,367
| +176% | +$2.63K | ﹤0.01% | 401 |
|
|
2023
Q2 | $1.77K | Sell |
1,918
-52
| -3% | -$48 | ﹤0.01% | 433 |
|
|
2023
Q1 | $2.15K | Buy |
1,970
+501
| +34% | +$546 | ﹤0.01% | 429 |
|
|
2022
Q4 | $2.15K | Buy |
1,469
+124
| +9% | +$181 | ﹤0.01% | 368 |
|
|
2022
Q3 | $1K | Buy |
+1,345
| New | +$1K | ﹤0.01% | 377 |
|